Location History:
- 00 Bjarred, SE (1986)
- 50 Bjarred, SE (1985 - 1990)
- Jagarevagen, SE (1991)
- Bjaerred, SE (2003)
- Bjarred, SE (1995 - 2014)
Company Filing History:
5 out of 42 
4 out of 184 
1 out of 27 Years Active: 1985-2014
Title: **Innovative Contributions of Anders K Bjork**
Introduction
Anders K Bjork, located in Jagarevagen, Sweden, is a distinguished inventor with a remarkable portfolio of 13 patents. His work primarily focuses on pharmaceutical compositions and methods, contributing significantly to advancements in medicinal chemistry.
Latest Patents
Among his latest innovations, Anders has developed a stable solid pharmaceutical composition consisting of crystalline salts of specific quinoline compounds. This composition includes an alkaline-reacting component that maintains the pH preferably above 8, along with at least one pharmaceutical excipient. One notable aspect of his development is that the salt of formula (II) is essentially stable during storage at room temperature for at least three years. Additionally, Anders has devised methods for preparing this crystalline salt and a process for stabilizing it.
Career Highlights
Anders K Bjork has made significant strides in the pharmaceutical industry through his inventions. He has contributed his expertise to companies such as Active Biotech AB and Pharmacia AB, where his innovative spirit has facilitated advancements in drug formulation and stability.
Collaborations
Throughout his career, Anders has collaborated with esteemed colleagues, including Gunnar Hedlund and Stig Jonsson. These partnerships have fostered an environment of creativity and innovation, allowing for the successful development of groundbreaking pharmaceutical solutions.
Conclusion
Anders K Bjork stands out as a prominent figure in the field of pharmaceutical innovation. His 13 patents not only reflect his dedication to advancing medicinal chemistry but also showcase his ability to create stable and effective pharmaceutical compositions. With a solid foundation built through collaboration and a focus on innovation, Anders continues to contribute to the evolving landscape of pharmaceuticals.